Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Trial of PEG-IFN-SA in HCV Disease: Evidence for Drug Safety, Tolerance, and Antiviral Activity

NCT01605513 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.

NCT NCT01605513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01605513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Trial of PEG-IFN-SA in HCV Disease: Evidence for Drug Safety, Tolerance, and Antiviral Activity
Lead sponsor
The First Hospital of Jilin University
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2013
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus